Additionally, glucocorticoids inhibit ILC2 function by suppressing IL-5, IL-13, and IL-9 production via MEK/JAK-STAT signaling pathways, as demonstrated in studies using ILC2s sorted from asthma patients’ PBMCs [187]. This evidence concerns the gene IL13 and asthma.